Zomig (zolmitriptan) Nasal Spray, AstraZeneca NDA 21-450 9/30/03 10/10/03 10/10/03 Zomig (zolmitriptan) tablets, AstraZeneca LP NDA 20-768/S-006 1/29/02 3/6/02 Zomig (zolmitriptan) tablets & Zomig-ZMT (zolmitritpan) Orally Disintegrating Tablets, AstraZeneca LP NDA 20-768/S-010 & 21-231/S-03 10/9/02 10/21/02 Zomig-ZMT (zolmitritpan) Orally Disintegrating Tablets, AstraZeneca NDA 21-231 2/13/01 3/30/01 3/30/01 Zomig Indications: Acute treatment of Migraine. Zomig (zolmitriptan) nasal spray, AstraZeneca, Labeling Revision | Zomig (zolmitriptan) Tablets, AstraZeneca Pharma, Patient Population Altered

For the most up-to-date approval information, please locate this API using the drug index.